NYSEFinancialsLife & Health InsuranceS&P MidCap 400
$55.45
-0.98 (-1.74%)
Close of Nov 06, 2026 · end-of-day data
CNO 8-K filings in 2026
Every material Form 8-K CNO Financial filed with the SEC in 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
CNO Financial Group reported third quarter 2026 net income of $161 million, or $1.71 per diluted share, up from $23.1 million, or $0.24, a year earlier. The company raised its full-year 2026 operating EPS guidance, with the midpoint up 9% from prior guidance. Total revenues fell to $1,086.0 million from $1,188.7 million, and $44.9 million of favorable significant items from the annual actuarial review boosted results.
Net operating income was $179.1 million, or $1.90 per diluted share, up 47% from $1.29 in 3Q25.
2026 operating EPS guidance midpoint raised 9% from prior guidance.
Total revenues were $1,086.0 million, compared with $1,188.7 million in 3Q25.
Significant items from the comprehensive annual actuarial review added $44.9 million, or $0.48 per diluted share, to 3Q26 results.
CNO Financial Group reported second quarter 2026 net income of $126 million, or $1.33 per diluted share, up from $91.8 million, or $0.91 per diluted share, a year earlier. The company also raised its full-year 2026 operating earnings per share guidance by 8% at the midpoint, which points to higher expected per-share earnings for shareholders.
Net income was $126 million, or $1.33 per diluted share, versus $91.8 million, or $0.91, in 2Q25.
Net operating income was $120 million, or $1.26 per diluted share, up 45% from $0.87 in 2Q25.
2026 operating EPS guidance raised by 8% at the midpoint from prior guidance.
Repurchased $60.0 million of common stock in 2Q26; authority to repurchase up to an additional $300.4 million remained at June 30, 2026.
CNO Financial Group reported first quarter 2026 net income of $38 million, or $0.39 per diluted share, up from $21.5 million, or $0.21 per diluted share, a year earlier. Net operating income, a non-GAAP measure, was $101 million, or $1.05 per diluted share, up 33% per share, and total revenues rose to $1,029.6 million from $1,004.1 million. Shareholders also face a lower book value per share of $26.64 at March 31, 2026, compared with $27.92 at December 31, 2025.
Net income was $38 million ($0.39 per diluted share) in 1Q26, compared with $21.5 million ($0.21) in 1Q25.
Net operating income was $101 million ($1.05 per diluted share), compared with $0.79 per diluted share in 1Q25.
Total revenues were $1,029.6 million, compared with $1,004.1 million in 1Q25.
CNO repurchased $60.0 million of common stock in 1Q26 and had authority to repurchase up to an additional $360.4 million.
CNO Financial Group's Board declared a $0.17 per share quarterly dividend, payable March 24, 2026. Director Nina Henderson, who joined the Board in 2012, will retire when her term ends at the May 12, 2026 annual meeting, and her decision was not based on any disagreement with the company. The Board will have nine directors after her retirement.
Quarterly dividend of $0.17 per common share, payable March 24, 2026, to holders of record at the close of business on March 10, 2026
Director Nina Henderson, who joined the Board in 2012, will retire at the conclusion of her current term at the 2026 annual meeting
Henderson chairs the Human Resources and Compensation Committee and is a member of the Investment Committee
Virtual annual meeting of shareholders on May 12, 2026, at 8:00 a.m. ET; holders of record on March 16, 2026 may vote
CNO Financial Group reported fourth quarter 2025 net income of $93 million, or $0.95 per diluted share, down from $183 million, or $1.74, a year earlier, mainly due to non-economic accounting impacts from market volatility. Net operating income, a non-GAAP measure that excludes those items, rose to $143 million, or $1.47 per diluted share, from $1.31 per share in the prior-year quarter. The company said it achieved, and in most cases exceeded, its 2025 guidance metrics.
Q4 2025 net income was $93 million ($0.95 per diluted share), versus $183 million ($1.74) in Q4 2024.
Q4 2025 net operating income was $143 million ($1.47 per diluted share), up 12% per share from $1.31.
Full-year 2025 net income was $229 million ($2.30 per diluted share), versus $421 million ($3.89) in 2024, including a $101.9 million goodwill and other asset impairment.
Full-year 2025 net operating income was $439 million ($4.40 per diluted share), up 11% per share; the company returned $386 million to shareholders.
CNO Financial Group's board appointed Linda T. Gibson as an independent director effective January 15, 2026, increasing the board to ten members. She joins the Audit and Enterprise Risk Committee and the Investment Committee, and her director pay will follow the company's standard non-employee director arrangements, prorated from her start date.
Linda T. Gibson appointed independent director on January 15, 2026; board size rises to 10
Gibson named to Audit and Enterprise Risk Committee and Investment Committee
Gibson formerly chaired and led PGIM Quantitative Solutions, 2021 to 2025
Company expects to sign an indemnification agreement with Gibson
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every CNO Financial filing is on SEC EDGAR ↗. 8-K briefs of other companies →